Peptide antibiotics possess a variety of chemical structures, e.g. cyclic di-and oligopeptides, depsipeptides, linear peptides with repeating sequences of Land o-amino acids, substituted peptides containing non-peptide components. These antibiotics frequently contain amino acids which are not constituents of proteins.
peptide antibiotics has revealed that a different type of mechanism is involved in their biogenesis in cantrast tothat described for cellular proteins 7 . Today I would like to discuss certain aspects of their biosynthesis.
First I wish to consider some of the properties of peptide antibiotics 8 • 9 which distinguish them from proteins ( Table 1) : Table 1 . Properties of peptide antibiotics 1. Molecular weight-350 to 3000. 2. Family of closely related substances produced by a microorganism. 3 . Some composed solely of amino acids; other contain amino acids plus other constituents. 4 . Unusual amino acids: o-amino acids, methylated amino acids, ß-amino acids, imino acids, basic amino acids, S-con taining amino acids. 5. Cyclic structures. 6 . Unusuallinkages or arrangements of amino acids. 7. Generally resistant to hydrolysis by peptidases and proteases (animal, plant).
(1) To begin with, peptide antibiotics are generally much smaller in size than proteins. The molecular weights of the antibiotics range from about 350 to 3000. However, not all peptide antibiotics are small. For example, neocarzinostatin, an acidic protein, possesses a molecular weight of 9000.
(2) Microorganisms generally synthesize a family of closely related substances rather than a single entity. The members of a group generally differ from each other by one or, at most, a few amino acids, the rest of the molecule being the same.
(3) Some peptide antibiotics are composed entirely of amino acids, whereas others contain fatty acids, pyrimidines, amino sugars, hydroxy acids, amines, and other constituents besides the peptide portion of the molecule.
(4) Frequently, peptide antibiotics containamino acids which are unique and are not found in proteins. For example, D-amino acids, methylated amino acids, ß-amino acids, imino acids, basic amino acids ( e.g. ornithine) and S-containing amino acids.
(5) Many antibiotics possess cyclic structures with no free Cl-amino or carboxyl groups. Besides the cyclic nature of a molecule, there may be unusual linkages or arrangements of the amino acids.
(6) Peptide antibiotics are generally resistant to hydrolysis by peptidases and proteases of animal and plant origin.
IN VIVO STUDIES A. Formation of peptide antibiotics in relation to growth and protein synthesis
A number of studies have shown that the synthesis of peptide antibiotics is initiated after the organism has passed the rapid growth phase. This has been noted in the case of actinomycin, triostin, gramicidin S, tyrocidine, polymyxin, and many other antibiotics 1 0-25 . In the case of actinomycin 10 , it has been reported that approximately 70 per cent of the growth of the organism is completed before antibiotic production is detected in the medium, and that very little growth occurs after the actinomycin titre reaches 15 to 20 J.Lg/ml of medium. Kurahasill et al. 12 • 13 showed that gramicidin S and the enzyme systems necessary for its synthesis were produced in cells of B.
brevis during the late log phase of growth. The specific as weil as total gramicidin S-forming activity was low at the mid log phase of growth, but they both increased abruptly and reached a maximum at the late log phase. The enzymatic activity for antibiotic synthesis then fell within a few hours to the Ievel of the middle log phase. The activity of an A TP-dependent phenylalanine racemase, involved in gramicidin S synthesis, followed the ~ame pattern 13 .
The synthesis of cellular proteins and of a peptide antibiotic by an organism also varies considerably during the course of growth and antibiotic formation26· 27 . During the period of rapid cell synthesis there is a maximal incorporation of a 14 C-labelled amino acid into cell proteins, but negligible incorporation of 14 C-label into antibiotic, as synthesis of the latter is generally not detected 26 . After the organism has entered the late log or stationary phase, there is considerably less incorporation of the amino. acid into protein (t to i). The synthesis of antibiotic is initiated during this period and incorporation of an amino acid precursor into an antibiotic increases appreciably with the length of incubation until maximum synthesis of antibiotic occurred.
B. Inhibitors of protein and nucleic acid synthesiS-antibiotics
Not only does antibiotic production follow maximal protein synthesis and cell growth, but it is now clear from studies with certain inhibitors of protein and nucleic acid synthesis that antibiotic synthesis is generally not blocked by these inhibitors. For example, chloramphenicol and puromycin markedly inhibited ( > 90 per cent) the incorporation of L-valine-14 C into cellular protein of S. antibioticus. By contrast, there was no inhibition of actinomycin synthesis and, in fact, a two-to three-fold stimulation of the incorporation of the Iabelied amino acid into the antibiotic was observed 10 · 26 · 28 . Streptomycin, neomycin, tetracycline and erythromycin, inhibitors of protein synthesis, also were found to stimulate actinomycin formation ( Table 2) . By contrast, vancomycin, penicillin, actinomycin and mitomycin C, inhibit0rs of cell wall or nucleic acid synthesis had no influence on actinomycin formation. The stimulation of incorporation of amino acids into actinomycin in the presence of chloramphenicol and the other antibiotics can be explained by the availability of the intracellular amino acid pool for antibiotic synthesis in the absence of protein synthesis 10 · 11 . Abraham et az.t suggested that a rate limiting factor for the biosynthesis of peptide antibiotics is the availability of precursors in the amino acid pool which could increase when the demands of protein synthesis fall off. This appears tobe the case, as our data suggest that appreciable competition for amino acids exists between the processes of antibiotic and protein biosynthesis.
Observations similar to those found for actinomycin have now been reported for a number ofpeptide antibiotics, e.g. polymyxin B 17 · 18 , edeine 29 , and triostin 11 . The formation of bacitracin 22 · 30 , tyrocidine 15 , or gramicidin31• 32 was also unaffected, but not stimulated by antibiotic inhibitors of protein and nucleic acid synthesis. However, Eikhom and Laland 33 have reported that there was enhanced incorporation of ornithine-14 C into gramicidin S in the presence of actinomycin D. 1700  0  chloramphenicol  3700  118  tetracycline  4000  135  neomycin  4200  147  Streptomycin  2900  71  erythromycin  2800  65  vancomycin  1700  0 Nisin, on the other hand, may be synthesized on a ribosomal template. Hurst 34 , and more recently, Ingram 35 , have reported that chloramphenicol, puromycin and terramycin were more effective inhibitors of nisin formation than of protein synthesis. Mitomycin C and actinomycin D affected nisin formation to a very limited extent, however.
C. Aminoacid and nucleic acid analogues
Amino acid and nucleic acid analogues have also been employed to differentiate between antibiotic peptide and protein synthesis. Winnick et al. 16 observed that 5-fluorouracil, 5-bromouridine and 5-fluorotryptophan were able to inhibit B. brevis growth and protein synthesis significantly with only slight or partial effects on gramicidin S synthesis. On the other hand, a number of amino acid analogues, e.g. norleucine, norvaline, fluorophenylalanine and hydroxyproline were highly inhibitory to gramicidin S formation without atTecting protein synthesis appreciably. Certain analogues of amino acids present in tyrocidine were also shown by Winnick et al. 36 to inhibit tyrocidine synthesis by B. brevis; at the same time, gramicidin formation was stimulated, and the incorporation ofvaline-14 C into gramicidin was enhanced when tyrocidine synthesis was partially inhibited. Mach et al. 15 also noted a selective effect of amino acid analogues on tyrocidine and protein synthesis. Some of their results are shown in Figure 1 . With most compounds examined, tyrocidine synthesis was almost completely stopped with only a limited effect (20 per cent) on protein synthesis. By contrast, some of the analogues proved tobe more inhibitory for protein synthesis. Similar effects have been observed with analogues structurally related to amino acids in the actinomycins
•
Thus, the results obtained with inhibitors of protein, RNA and DNA synthesis indicate that there is not a direct involvement of DNA or RNA in peptide antibiotic synthesis.
D. Controlled or directed biosynthesis
In vivo studies also have suggested that antibiotic formation is catalysed by enzymes with relatively broad specificities, as the mechanism for the recognition of amino acids incorporated at certain positions in a number of different peptide antibiotics appears to have a lower specificity than the corresponding one for protein synthesis. Amino acid substitutions in peptide antibiotics have been reported by several investigators 38 -50 . This controlled or directed biosynthesis in vivo has been achieved by employing two nitrogen compounds in the culture medium. One compound serves as nitrogen source for protein and nucleic acid synthesis and hence growth. The second nitrogen compound serves to direct or influence antibiotic formation. The exogenously supplied compound (identical or chemically similar) competes with an endogenously synthesized amino acid for the latter's site in the peptide and either (i) is incorporated into the antibiotic peptides with increased formation (2) tyrosine ( 1) tryptophan (1) Phenylalanine (1) tyrosine ( 1) tryptophan ( 
N of eertain traee eomponents or the formation of new antibiotics, or (ii) is incorporated after enzymatie modifieation. In some instanees the exogenously supplied eompound may selectively inhibit synthesis of only eertain of the antibioties formed by an organism. Some examples of amino aeid substitutions or replaeements are presented in Table 3 .
The speeifieity of the amino aeid sequenee in a protein is determined genetieally. and the translation of a nucleotide sequenee into a sequenee of amino aeids generally oeeurs with virtually absolute speeifieity 51 -58 . Single amino aeid substitutions observed in proteins, e.g. tryptophan synthetase, phage eoat proteins, haemoglobin or tobaeeo mosaie virus, are due to ehanges in the nucleotide sequenee of struetural genes rather than due to variations in environmental or metabolie eonditions 59 • 60 . Although the ineorporation of eertain amino aeid analogues into protein has been frequently shown, there is no eompetition between the naturally oeeurring amino aeids of proteins. Supplying ]arge exeesses of eertain amino aeids does not result in a single amino aeid substitution involving these amino acids, e.g. isoleueine for valine or tryptophan for phenylalanine. The formation of an aminoaeyl-tRNA in vitro is eharaeterized by a rigorous speeifieity. Isoleueyl-tRNA synthetase eatalyses the formation of an enzyme-bound aminoaeyl adenylate with either L-isoleueine or L-valine. The enzyme, however, transfers isoleueine but not valine to the homologaus isoleueyl tRNA 52 • 5 4-
.
Valine is released from the enzyme as the free amino aeid in the presenee of isoleueyl tRNA.
The tyroeidines, aetinomyeins, quinomyeins, and many other peptide antibiotics synthesized by an organism normally difTer, respeetively, by single amino aeid substitutions. lf antibiotie synthesis were under direet genetie eontrol, then, a priori, it would be neeessary to assume that different strains within the eulture would be involved in the synthesis of the individual eomponents of an ·antibiotie family. It has been shown, however, that a single clone isolated from a eulture produees all of the various forms of aetinomyein or tyroeidine. Another less likely possibility would be the existenee, in the DNA of eaeh eell, of several templates differing from one another by single nucleotide substitutions and direeting the simultaneaus synthesis of almost identieal polypeptides. Although this possibility exists, it appears more likely that amino aeid substitutions in antibiotie peptides are probably not the result of different templates arising through gene mutations, but rather depend on physiologieal and environmental faetors. The synthesis of different forms of an antibiotie eomplex by a mieroorganism is, of eourse, genetieally determined in sofaras the elaboration of the enzyme systems for antibiotie synthesis is eoneerned. However, due to the relatively broad speeitieity of the speeifie enzyme systems, environmental and physiologieal eonditions may int1uenee quantitatively and qualitatively what is aetually produeed.
CELL-FREE STUDIES A. General properties
The most eonclusive evidenee for the nonribosomal synthesis of peptide antibioties has been obtained from eell-free systems. The eell-free synthesis of gramieidin S 73 has been reported and it is evident that these systems are distinct from those synthesizing proteins. The requirements for synthesis ofthe antibiotics are fairly similar and generally include the requisite amino acids of the peptide antibiotic in question, A TP as energy source, occasionally an A TP generating system is required, Mg 2 + ion, a reducing agent and the particle-free supernatant. Some laboratories have purified the enzymatic system by differential centrifugation, (NH 4 ) 2 S0 4 fractionation, and column chromatography with DEAE cellu1ose, Sephadex G-200 or hydroxylapatite. The peptide synthesizing systems are reported to l'e irrsensitive to ch1oramphenico1, puromycin, DNAse and RNAse.
B. Amino acid activation
Until recently, investigations concerning the activation of amino acids for antibiotic synthesis did not shed much light on the specitic nature of the process for antibiotic synthesis since components of the protein synthesizing system were still present in cell-free extracts. Activation of an amino acid for protein synthesis requires ATP, Mg 2 + and a specific aminoacyl-tRNA synthetase. The enzyme bound aminoacyl adenylate is then transferred to a specific tRNA molecule. How then does one distinguish between the two kinds of activating enzymes in cel1-free extracts of an organism? One approach would be to employ amino acids which are unique to antibiotic peptides and arenot present in proteins. A second approach, since the in vivo studies have indicated that antibiotic synthesis does not involve RNA directly, would be to demonstrate the activation of an amino acid without its subsequent transfer to a tRNA specific for that amino acid as would be the case in protein synthesis. If the activated amino acid was then incorporated directly into the antibiotic peptide, this would clearly constitute ä separate and distinct system for activation of amino acids for antibiotic synthesis.
Earlier studies had shown that a nurober of the L-amino acids in peptide antibiotics were activated by cell-free extracts: on the other hand, activation of the n-amino acids has been described as negligible to good. In these early attempts it was not demonstrated that the activated amino acid was employed specitically for synthesis of the antibiotic. In some cases, an ATP-pyrophosphate exchange reaction has been observed with amino acids unique to antibiotics. Brenner, Gray and Paulus 74 found an L-ex., y-diaminobutyrate dependent exchange in extracts of a strain of B polymyxa. The enzyme was partially puritied and was shown to be highly specific for the amino acid. Evidence that the enzyme is involved in polymyxin synthesis was deduced from the fact that mutants unable to produce the antiobiotic lacked the ability to activate L-et, y-diaminobutyrate. Ciferri et al. 75 , however, noted that the A TP-PPi exchange reaction with this amino acid occurred with extracts obtained from only one of two polymyxin-producing strains tested. Otani et al. 76 have reported achieving a 30-fold purification of the ornithineactivating enzyme from extracts of B brevis, producer of gramicidin S. The specific activity of the ornithine-activating enzyme was found to almost parallel that of gramicidin S formation. No formation of ornithinyl-tRNA was observed. This enzyme is part of a multi-enzyme complex required for gramicidin S synthesis (see below).
A number of laboratories have examined gramicidin S (Figure 2 an A TP-dependent activation and racemization of L-phenylalanine ~ Dphenylalanine occurred with fraction II. The activation process, measured by the ATP-P~ exchange reaction, appears tobe quite specific since relatively few amino acids other than the ones present in gramicidin S were activated. Aminoacyl-tRNA was not formed with either fraction I or II under conditions of ATP activation using B brevis or E. coli tRNA and any one of the five gramicidin S amino acids. These data, along with the finding that gramicidin S synthesis is not inhibited by chloramphenicol, puromycin or RNAse, demonstrates that antibiotic synthesis occurs in the complete absence of polynucleotides. As pointed out by Roskoski et al. 66 the amino acid sequence in antibiotics such as gramicidin S or tyrocidine is determined by enzyme speciticity and organization of the enzyme complex and not by RNA templates.
Kleinkauf et al. 63 • 77 • 79 have suggested that fraction I contains four activating enzymes (proline, valine, ornithine and leucine) organized into a tightly associated multi-enzyme complex. Sucrose density gradient centrifugation studies have indicated that its molecular weight is ab out 280 000. Experiments carried out with fraction I reveal that there is a 1:1:1: 1 stoichiometric binding of the amino acid substrates to the complex when the amino acids are added singly or in various combinations (with ATP + Mg 2 +) (Table 4 ). When purified fraction I charged with all four amino acids was Table 4 . Binding of four amino acids to fraction 1 Recent evidence has indicated that there are secondary acceptors of the bound amino acids on the enzymes and that these· are sulphydryl groups
Amino acids added -----Amino acids bound (JlJlmoles
These -SH groups are reversibly esteritied by transfer of the aminoacyl moieties from the aminoacyl adenylates. Evidence for the formation of covalent thioester bonds between the individual amino acids and the specific enzymes involved is as follows: (1) Acid stability-when a charged amino acid-enzyme complex I is precipitated with trichloroacetic acid, all of the bound adenylate is released, but only one half of the bound amino acid is liberated. (2) Dilute alkali (pH 9 .0) or mercuric salts at neutral pH bring about a quantitative discharge of the amino acids from the trichloroacetic acid precipitates. (3) Hydroxylamine treatment of the precipitates releases the amino acids as hydroxamates. ( 4) Sodium borohydride reductively cleaves the bond with release of the corresponding amino alcohol.
Similarly, an aminoacyl adenylate complex is formed between fraction li (mol. wt. 100000) and phenylalaninein the presence of ATP and Mg 2 +. The reversible formation of a thioester bond between phenylalanine and an SH group on fraction li follows the initial activation step (Figure 4) . 
C. Initiation of peptide bond synthesis
Several groups have reported finding small amounts of free peptide derivatives after in vitro incubations 78 • 83 -86 . Compounds such as o-phenylalanyl-L-prolyl diketopiperazine as weil as a tri-and tetrapeptidc have been detected. While it is generally believed that free peptide intermediates are not involved in gramicidin S synthesis and that these compounds are probably artifacts of the cell-free incubation conditions, it is of interest to note that they were all found to contain D-phenylalanine in the N-terminal position next to L-proline. Based on this finding it was considered likely that the starting point for gramicidin S synthesis is at the n-phenylalanine residue bound to fraction II and that the direction of peptide chain growth is from the N-terminal to the C-terminal position as in protein synthesis 78 • 85 • It is now clear that peptide chains are formed with D-phenylalanine at the N-terminal position and that only enzyme-bound intermediates are involved in gramicidin S formation 7 9 • 82 • 87 . Recently, Ljones and co-workers 8 8 described in vitro pulse-chase experiments with labelled amino acids which indicated that protein-bound intermediates participate in gramicidin S synthesis. Gevers et al. 82 and Froshov et al. 87 have conclusively demonstrated that protein-bound covalently-linked peptide intermediates are formed during suitable incubations. These can be released from the protein (fraction I) by addition of hydroxylamine or performic acid oxidation. They found that n-phenylalanyl-L-proline, D-phenylalanyl-L-prolyl-L-valine, n-phenylalanyl-L-prolyl-L-valyl-L-ornithine, and even small amounts of the pentapeptide were present on the enzyme. Thus, during peptide synthesis the amino acids are added singly until a pentapeptide is formed. Elongation of the gramicidin S peptide chain takes place in a fixed order of amino acid additions. Omission of one aminoacidwas shown to interrupt the elongation process.
Lipmann et al. is joined to ornithine and, finally, the pentapeptide is synthesized by addition of leucine. The energy-rich thioester bonds provide the driving force for peptide-bond synthesis. The absence of peptide chains containing more than five amino acids suggests that these may never be formed. Lipmann's group has proposed that the cyclic decapeptide of gramicidin S may arise by an antiparallel doubling reaction between two carboxyl activated pentapeptidyl units, presumably attached to different fraction I components
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. Stoll et al. 89 , however, have very recently presented evidence suggesting that two pentapeptide chains attached to the same enzyme I molecule cyclize by head to tail condensations to yield a molecule of gramicidin S, i.e. that the cyclization is an intra rather than an inter molecular reaction.
D. RoJe of phosphopantotheine in peptide synthesis
Gevers et al. 82 advanced the interesting hypothesis that antibiotic peptide synthesis may be analogaus to fatty acid elongation that occurs in a polyenzyme complex (fatty acid synthetase). On the basis of this similarity, it was suggested that pantotheinemay play a role in peptide antibiotic synthesis. The first direct evidence, however, was provided by Gilhuus-Moe et al. 81 who demonstrated that pantothenic acid was present only in enzyme fraction I of the gramicidin S system. Based on microbiological assays, 0.8 mole of phosphopantothenic acid was found per mole of enzyme I. Kleinkaufet al. 90 confirmed that of the two complementary fractions, only the heavy one which carries 4 thioester-linked amino acids contains 1 mole of pantotheinejmole of enzyme. They also showed that 14 C-pantothenate was incorporated by B. brevis into the gramicidin S enzyme system. Subsequent separation by Sephadex column chromatography revealed that only fraction I contained bound 14 C-pantothenic acid. It was also reported 90 that pantotheine is present only in the heavy fraction of the enzymes that participate in tyrocidine synthesis (1 mole of pantotheine per mole of enzyme).
By analogy with its proposed function in the case of the fatty acid synthetase in fatty acid synthesis. Gilhuus-Moe et al. 81 have proposed that phosphopantotheine acts like an arm to accept the growing peptide chain after each succesive peptide bond is formed and to transfer the peptide to the next thioester-linked amino acid in sequence. Kleinkauf et al. 90 have considered a similar role for the . compound; they have whimsically proposed that the coenzyme acts like ä merry-go-round. Presumably then, one can think of the amino acids as the brass rings. More precisely, the phosphopantetheine is thought to function in vectorial peptidyl transfer reactions in which it alternates as acceptor of the growing peptide chain and donor to the free amino group of the next thioester-linked amino acid in sequence for peptide bond synthesis.
E. Tyrocidine formation
Kurahashi et a/.
14 • 65 first obtained evidence for the cell-free synthesis of tyrocidine. They reported that two protein fractions were necessary for tyrocidine synthesis. One fraction activated and racemized phenylalanine, whereas the second fraction was believed to function for the activation of the other amino acids in tyrocidine.
Recently, however, Roskoski et al. 66 • 67 • 90 resolved the enzymatic sys.tem more extensively and found that each of three enzyme fractions are required for tyrocidine formation. The individual components catalyse ATP-32 PPi exchanges depending on the constituent amino acids. The molecular weights of the three components based on Sedimentation coefficients by sucrose density centrifugation, as weil as the amino acids activated by the individual components, are shown in Table 5 . The light fraction displayed D-and Lphenylalanine dependent ATP-PPi exchange activity and catalysed the racemization of phenylalanine. There was no dernonstrahle phenylalanyltRNA synthetase activity in the preparation. The intermediate fraction activated L-proline but was free of proline-tRNA synthetase activity. The heavy fraction contained exchange activities dependent on the amino acids which occur in positions 3-10 in the tyrocidine molecule and was free of the corresponding tRNA acylating enzymes. As in gramicidin S synthesis. each of the aminoacyl moieties of the aminoacyl adenylates was transferred to secondary acceptors (thiol groups). Evidence was also provided that chain growth in tyrocidine biosynthesis begins with the N-terminal amino acid, D-phenylalanine, and proceeds in order to the carboxyl terminus ending with leucine. It is believed that a linear decapeptide is formed on the heavy fractions are combined (Figure 7) . Thus, the light component with bound nascent peptides are protein-bound. The light, intermediate and heavy fractions can carry charged, i.e. activated, amino acids without polymerization. Polymerization occurs only when the fractions are combined (Figure 7) . Thus, the light component with bound phenylalanine initiates peptide synthesis on the intermediate fraction by reacting with bound proline to form H 2 N-phenylalanyl-prolyl-thioenzyme. This reacts with the third amino acid, i.e. with the amino group of the phenylalanyl thioester on the heavy component, forming a tripeptidyl thioenzyme and so on until a decapeptide is formed. Finally, the leueine carboxyl group is believed to react with the free amino group of D-phenylalanine at the N terminus of the peptide chain resulting in cyclization and release of a tyrocidine molecule. Chain elongation is halted when one of the amino acids tyrocidine molecule is thought to be a relatively slow reaction in contrast to the cyclization step in gramicidin S synthesis. As mentioned previous1y, phosphopantotheine is found only on the heavy fraction of the tyrocidine system, and its role in tyrocidine synthesis is considered to be analogaus to that described ear1ier for gramicidin S formation 90 .
F. Heterologous versus homologous systems
Roskoski et al. 66 have reported that when fraction II of the gramicidin S synthesizing system (activates and racemizes phenylalanine) is substituted for the tyrocidine light component in an otherwise complete tyrocidine synthesizing system, no antibiotic synthesis occurred. Similarly, the tyrocidine light fraction did not promote gramicidin S formation in the presence offraction I (gramicidin S system). These resu1ts suggest a lack ofheterologous complementarity between the gramicidin S and tyrocidine synthesizing systems. This observation differs, however, from that described earlier by Kurahashi et al. 75 who had reported that the purified phenylalanine racemase from their gramicidin S system cou]d substitute for the tyrocidine light fraction (their fraction 1). The reason for this discrepancy is not clear at the present time.
G. Enzyme specificity
Wehave already discussed that structurally related compounds can replace amino acids during the synthesis of the actinomycins, quinomycins, tyrocidines and other peptide antibiotics in vivo. Such data suggested that the enzyme systems had relatively broad specificities for particular amino acids. Cell-free studies with the tyrocidines and gramicidin S systems have provided additional proof for this hypothesis. For example, leueine can be replaced by isoleucine, ornithine by lysine, and tyrosine by phenylalanine in the enzymatic synthesis of tyrocidine 65 . Moreover, if tryptophan was omitted from incubation mixtures, tyrocidine A (2-phenylalanine, 1 tyrosine, 0 tryptophan) was synthesized preferentially. lt has also been shown that azetidine-2-carboxylic acid can substitute for proline in the cell-free synthesis of gramicidin 8 89 . In addition, certain amino acid analogues (5-methyltryptophan, p-fluorophenylalanine, thienylalanine, and p-fluorotryptophan) not only promote an ATP-32 PPi exchange reaction but also can be incorporated into tyrocidine in vitro.
H. D-Amino acids
Few studies have been reported on the biosynthesis of the amino acids which are unique to peptide antibiotics, e.g. the imino acids, N-methylamino acids, ß-amino acids, and D-amino acids. Most attention has centred on the formation of n-amino acids.
The mechanism of biogenesis of D-amino acids, however, has still not been fully elucidated. In most cases, in vivo studies have revealed that the L-amino acid, but not the D-isomer, is the precursor of the D-amino acid in the antibiotic22· 26 · 92 -94 . In a few instances the n-amino acid can be employed but not as etl'ectively as the L-enantiomorph 69 · 95 . Some investigators have reported that the n-amino acid inhibited antibiotic synthesis which was reversed by the L-amino acid 96 -98 .
Yukioka and Winnick 69 observed that both o-and L-leucine were utilized for malformin synthesis in vitro. However, an excess ofL-leucine-12 C strongly depressed D-leucine-14 C incorporation whereas an excess of D-leucine-12 C had relatively little etl'ect on the incorporation of L-leucine-14 C. Several groups have noted that both D-and L-phenylalanine can be utilized for the cell-free synthesis of the D-phenylalanine residue in gramicidin s12-14,27,63,66,67,7 7 -7 9, 100 -102 . lt was noted generally that the L-isorner was preferentially employed. Bacitracin contains a residue each of nasparagine, n-phenylalanine, n-ornithine and D-glutamic acid. Ishihara et al. 71 reported that addition of the D-isomers, singly or in combination, instead of the corresponding L-forms markedly depressed the incorporation of L-histidine-14 C into the antibiotic in vitro.
An ATP-dependent racemization of phenylalanine by cell-free extracts of B. brevis strains that produce gramicidin S was first described by Yamada et al. 102 . It has been well established since then that the enzyme is involved in the formation of the n-phenylalanine residue in gramicidin s13,63, 77, 79,82,100-102 ancl tyrocidine66,67, 78,
The enzymewas reported to require ATP, Mg 2 + and PPi for its action and the racemase activity could not be separated from the phenylalanine (D- or L-) activating activity. It was proposed 13 that L-phenylalanine was activated by ATP forming an enzyme-bound L-phenylalanyl adenylate which was converted to its o-form on the enzyme (Figure 8) . Release of the o-amino acid was pictured as a pyrophosphorylation of the o-aminoacyl adenylate to yield D-phenylalanine. The ratio of L-phenylalanine to o-phenylalanine at equilibrium was reported to be 3 to 7. When the enzyme was purified to near homogeneity~ it was clear that a mechanism other than pyrophosphorylation had tobe considered for the last step 101 . It was suggested that the final reaction might be a hydrolytic one, i.e. the hydrolysis of D-Phe-AMP-enzyme to yield D-Phe + AMP + Enz.
As we have already noted, Gevers et al. 68 • 82 reported that L-phenylalanine is activated by ATP with the formation of an L-phenylalanyl adenylateenzyme complex (fraction II, gramicidin S: light fractio~ tyrocidine). The aminoacyl moiety is then transferred to a thiol group on the enzyme to form a covalent thioester bond. Gevers et al. 82 have provided evidence that the racemization of phenylalanine occurs when the amino acid is present in the thioester form. The ratio ofL-phenylalanine to n.;.phenylalanine at equilibrium was determined to be 1:1 and these results have been contirmed by Kurahashi et al. 78 . Generallyamino acid racemases require pyridoxal phosphate or FAD or both for their activity. No evidence has been provided that either of these cofactors is involved in the reaction. The mechanism of the reaction~ therefore, is still not entirely clear. Moreover, the nature of the racemization reaction involving phenylalanine or tryptophan at position 4 in a tyrocidine molecule has not been elucidated.
DISCUSSION
In an earlier review 8 oftbis subject I entitled my paper Peptide AntibioticsProteins that Never Grew Up? The title may have been misleading since it implied that these compounds are primitive proteins. At the time no attempt was made to consider them in that light. Little was known of the mechanism of peptide antibiotic synthesis; however, it was recognized that the first step in the biogenesis of these compounds was an activation of an amino acid by ATP in the presence of Mg 2 + presumably with the formation of an aminoacyl adenylate. This reaction appeared tobe the only one in common with protein synthesis and was the reason for selecting such a title. Although the suggestion has been made that peptide antibiotics may represent primitive proteins 7 , it is quite evident from the elegant studies carried out in a number of laboratories that the biosynthesis of peptide antibiotics is directed by multi-enzyme complexes and that these complexes consist of proteins. Hence, the notion that primordial soups begat peptide antibiotics seems quite unlikely.
As we have noted earlier amino acids for antibiotic synthesis are activated by ATP to form enzyme-bound aminoacyl adenylate complexes. The aminoacyl moiety is then transferred to a specific -SH group to form a covalent thioester bond. The broader or lower specificity of the antibiotic synthesizing systems is most likely due to the fact that there are no aminoacyltRNA synthetases, specific tRNAs or mRNA molecules to selectively direct the incorporation of a specific amino acid into its site in a protein. In antibiotic synthesis once an amino acid or a related compound is activated, it is generally transferred to the specific -SH group and ultimately into the antibiotic. There appears to be less selectivity in these systems.
In antibiotic synthesis, the enzyme complex serves as template for the proper sequencing of the amino acids in the peptide. The processes of initiation, elongation and termination are inherent properties of the enzyme systems. As in ribosomal polypeptide synthesis, chain growth starts from the N-terminal position and ends at the carboxyl terminus end. However, the resemblance appears to end here. Phosphopantotheine has been shown to play an important role in the process of peptide chain elongation and hence there appears tobe a similarity between antibiotic peptide synthesis and fatty acidelongationcatalysed bypolyenzymesystems(fattyacidsynthetases)
